FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to the use of an immunomodulatory agent for intramuscular injections containing formic aldehyde in amount of 0.076–0.078 % in isotonic sodium chloride solution of 0.85–0.95 % concentration.
EFFECT: increased membrane potential of mitochondria and increased oxygen-dependent metabolism of neutrophils.
1 cl, 6 dwg, 4 tbl, 2 ex
Authors
Dates
2022-01-31—Published
2021-07-12—Filed